Deacylated lipopolysaccharide inhibits neutrophil adherence to endothelium induced by lipopolysaccharide in vitro.
about
Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementationPseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infectionIdentification of acyloxyacyl hydrolase, a lipopolysaccharide-detoxifying enzyme, in the murine urinary tractLipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathwayHaemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat.Expression of a Porphyromonas gingivalis lipid A palmitylacyltransferase in Escherichia coli yields a chimeric lipid A with altered ability to stimulate interleukin-8 secretion.Modulation of lipopolysaccharide-induced macrophage gene expression by Rhodobacter sphaeroides lipid A and SDZ 880.431Chapter 2: Kill the bacteria...and also their messengers?Deacylation of purified lipopolysaccharides by cellular and extracellular components of a sterile rabbit peritoneal inflammatory exudate.Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitroCooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitroComparison of lipopolysaccharides from Brazilian purpuric fever isolates and conjunctivitis isolates of Haemophilus influenzae biogroup aegyptius. Brazilian Purpuric Fever Study GroupDiphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide.Antilipopolysaccharide factor from horseshoe crab, Tachypleus tridentatus, inhibits lipopolysaccharide activation of cultured human endothelial cells.Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-gamma in a highly polarized fashionStimulus-dependent deacylation of bacterial lipopolysaccharide by dendritic cells.Salmonella enterica serovar Typhimurium expressing mutant lipid A with decreased endotoxicity causes maturation of murine dendritic cellsCell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cellsIn vivo inhibition of lipopolysaccharide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone inductionDiphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in miceEnzymatically deacylated Neisseria lipopolysaccharide (LPS) inhibits murine splenocyte mitogenesis induced by LPS.Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid XStructural requirements of lipid A for endotoxicity and other biological activities.A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14.Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion.Activation of human endothelial cells by viable or heat-killed gram-negative bacteria requires soluble CD14.Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures.Diphosphoryl lipid A derived from lipopolysaccharide (LPS) of Rhodopseudomonas sphaeroides inhibits activation of 70Z/3 cells by LPS.Intracellular and extracellular enzymatic deacylation of bacterial endotoxin during localized inflammation induced by Escherichia coli.Antagonistic lipopolysaccharides block E. coli lipopolysaccharide function at human TLR4 via interaction with the human MD-2 lipopolysaccharide binding site.Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide.Alkali-treated LPS of Yersinia enterocolitica does not induce expression of E-selectin, ICAM-1 or VCAM-1 on endothelial cells but may mediate antibody- and complement-dependent cell injury.The microbial challenge in periodontitis.Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo.Gram-negative bacterial lipopolysaccharide retention by a positively charged new-generation filter.Intravital microscopy of the murine urinary bladder microcirculation.
P2860
Q24670236-4B30D72D-7901-486C-8BF4-0AAD75528E5CQ28472320-3634065E-3B63-4701-AA2E-2B697C6BBCC0Q28509267-192D151D-E905-4FD3-AEF8-11C9C57359A4Q28756455-32E58125-BF45-4D41-ADF3-AAC6982875B3Q30449332-02D01061-97C4-402C-AB66-D0D8AC8C31D2Q33230005-0B304B85-9FF4-4968-8716-6001ED6268D7Q33606001-C6765E5A-6116-4DD9-AD33-5F5D840AEAFEQ33616742-3F847F85-EB56-4E1F-A2B6-7DD4DD31963CQ33876722-1EA26CEE-2999-418E-BED5-56F6990EFA9EQ34237390-A1598945-C3EB-4912-AA89-D507D4CAD183Q34575307-225BEA7D-08CB-4EB0-AD30-5FA9E70C65E7Q34679871-B3C879A0-CAE4-46A6-91A9-77C3746B2A00Q35094873-38FDBDD7-9E75-4403-86B5-253E89F26050Q35096235-D0B609FF-CD2E-4101-B0D0-109FEE7117B9Q35176262-A1A2BC80-7630-462A-8893-C1D883B70CB2Q36232379-8E6E0B2C-6529-4EF8-8EFA-084442187563Q36370898-302B6693-EAF7-4C60-940B-01B400FA4FD5Q36375529-454A4065-018A-4060-A4DC-A2C7D1645AD0Q36619988-CAC16E81-092F-4503-9096-39DB4E060B26Q36946846-46B54E92-8B66-400E-8A72-3F9D05FAED1BQ36960420-19BE7BD3-4E7C-481B-8F01-97312C78E22BQ36964293-30715037-7EDA-4CD2-8217-B757C104E17DQ36966474-A1FB292C-9725-41BB-A647-F5A8B76F4C9CQ38656773-FC965307-B4AB-4578-B44C-B7A8F11BB275Q39757929-712346DB-8ED3-4038-ACE1-A0DE2894526DQ39821499-A08333E2-FD04-4879-892D-C7686BAA797EQ39821679-DD81E303-B116-4092-9E1A-B900CE1A443FQ39823220-CF1024E9-E16B-41CE-9DC6-114F4A069C31Q40147608-B64C753E-837E-415C-8507-0A28E157AFE0Q40149542-7F084978-113D-4A44-8124-6C8B5F43F734Q40149843-61D2C70B-693B-4206-B2BF-C51A94214A33Q40184272-ABD0BB60-16AD-4580-8122-1B1F8A974982Q40269153-9118C937-4630-4DB7-AECE-1C787ADDC7EBQ41500086-04FAA1BC-0481-44B6-AD52-FF0FB72A2264Q41754941-32A847F3-8795-4D8A-9955-342021035934Q42046495-6B31FACD-9029-49DB-9A10-FCB23217D77BQ43247332-3933FE26-157E-4BEC-AC81-78CD30D88AB9Q54356347-69E3F540-DC43-432B-81B3-CA1C903CA521
P2860
Deacylated lipopolysaccharide inhibits neutrophil adherence to endothelium induced by lipopolysaccharide in vitro.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Deacylated lipopolysaccharide ...... y lipopolysaccharide in vitro.
@en
type
label
Deacylated lipopolysaccharide ...... y lipopolysaccharide in vitro.
@en
prefLabel
Deacylated lipopolysaccharide ...... y lipopolysaccharide in vitro.
@en
P2093
P2860
P356
P1476
Deacylated lipopolysaccharide ...... y lipopolysaccharide in vitro.
@en
P2093
J M Harlan
R S Munford
T H Pohlman
P2860
P304
P356
10.1084/JEM.165.5.1393
P407
P577
1987-05-01T00:00:00Z